Evidence map›Paper›PMID 42273095›Full record

ArticleQuantitative imaging in medicine and surgery2026

Deep learning-based Breast Imaging Reporting and Data System classification and establishment of diagnostic model in breast cancer diagnosis with automated breast ultrasound.

Xinyi Zhou, Mingwang Xu, Gongning Luo, Xitian Liang, Fan Yang, Bo Li, Shanshan Sun, Xiaoshuan Liang, Wenjuan Peng, Zhao Liu and 3 more

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xinyi Zhou *Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Mingwang Xu *School of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Gongning LuoSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Xitian LiangDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Fan YangDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Bo LiDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Shanshan SunDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Xiaoshuan LiangDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Wenjuan PengBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zhao LiuDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Yue LiDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Wen Cheng *Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Qiucheng Wang *Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Deep learning (DL) holds substantial promise for ultrasonography interpretation. However, there is limited research on the differential diagnosis of tumors in automated breast ultrasound (ABUS). This study constructs a breast cancer diagnosis model based on DL-adjusted Breast Imaging Reporting and Data System (D-BI-RADS) and determines its diagnostic performance. Methods: This retrospective study evaluated 786 patients with 832 breast nodules who underwent ABUS examination, follow-up or surgery from November 2018 to January 2022. The three-dimensional (3D) Vision Transformer (ViT) DL diagnostic models (DMs) were established and ABUS BI-RADS was adjusted to D-BI-RADS. With univariable and multivariable logistic regression, incorporating ABUS features and D-BI-RADS, three breast cancer DMs were constructed. Area under the receiver operating characteristic curve (AUC) was compared between DL, ABUS BI-RADS, and D-BI-RADS. In addition, the three DMs were verified in the validation set and test set. Results: The training, validation, and test data sets included 599 [mean age, 55±1.41 years; 351 (58.5%) malignant], 67 [mean age, 47.5±0.71 years; 40 (59.7%) malignant], and 166 [mean age, 61.5±4.95 years; 96 (57.8%) malignant] nodules. In the training data set, the D-BI-RADS showed improved performance in breast cancer diagnosis [AUC, 0.82; 95% confidence interval (CI): 0.79-0.85; P<0.01] compared with A-BI-RADS. With BI-RADS category 4b (3.5) as the cut-off value for benign and malignant diagnosis, the D-BI-RADS showed improved performance (AUC, 0.919; 95% CI: 0.896-0.941). In addition, Logistic, Random Forest, and Support Vector Machine (SVM) methods achieved ideal performance in the test set (AUC, 0.93; 95% CI: 0.89-0.97; AUC, 0.934; 95% CI: 0.897-0.972; AUC, 0.938; 95% CI: 0.901-0.974; respectively). Conclusions: The DL can be a useful adjunct guide to the adjustment of BI-RADS, and the established DMs achieved ideal diagnostic performance in breast cancer.

Indexed as

automated breast ultrasound (ABUS)Breast cancerBreast Imaging Reporting and Data System (BI-RADS)deep learning (DL)

Identifiers

PMID42273095
PMCPMC13247880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.